KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Medtronic (MDT) EBIAT (2016 - 2026)

Medtronic's EBIAT history spans 13 years, with the latest figure at $1.1 billion for Q1 2026.

  • On a quarterly basis, EBIAT fell 12.28% to $1.1 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $4.6 billion, a 7.3% increase, with the full-year FY2025 number at $4.7 billion, up 25.83% from a year prior.
  • EBIAT hit $1.1 billion in Q1 2026 for Medtronic, down from $1.4 billion in the prior quarter.
  • Over the last five years, EBIAT for MDT hit a ceiling of $1.5 billion in Q1 2022 and a floor of $435.0 million in Q4 2022.
  • Historically, EBIAT has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2026.
  • Biggest five-year swings in EBIAT: crashed 66.97% in 2022 and later skyrocketed 109.43% in 2023.
  • Tracing MDT's EBIAT over 5 years: stood at $435.0 million in 2022, then skyrocketed by 109.43% to $911.0 million in 2023, then soared by 40.29% to $1.3 billion in 2024, then grew by 8.06% to $1.4 billion in 2025, then decreased by 17.23% to $1.1 billion in 2026.
  • Business Quant data shows EBIAT for MDT at $1.1 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.0 billion in Q3 2025.